Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NEOGENOMICS INC Director's Dealing 2011

Oct 27, 2011

32227_dirs_2011-10-27_dd11a2d2-5bb9-45b7-8dca-24f8f2a188b4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NGNM.OB)
CIK: 0001077183
Period of Report: 2011-10-26

Reporting Person: CARDOZA GEORGE (CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-10-26 Common Stock P 3000 $1.21 Acquired 41676 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 20000 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock options (Right to Buy) $1.55 2014-11-30 Common Stock (150000) 0 Direct
Stock options (Right to Buy) $1.46 2016-04-14 Common Stock (100000) 0 Direct

Footnotes

F1: The amount includes exempt purchases made under the Company's stock purchase plan.

F2: On November 30, 2009 Mr. Cardoza was granted an option to purchase 150,000 shares. The options were all time based and vest ratable over each of Mr. Cardoza's first four anniversaries with the Company.

F3: On April 14, 2011 Mr. Cardoza was granted an option to purchase 100,000 shares. 75% of these options vest ratably at the first three anniversary dates of the grant and 25% of the options are performance based.